SCHEMBL7225529

SCHEMBL7225529

CCCCCCCCOc1cc(C)[c]c(C)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 2/20 0.51
NR5A1 Q13285 1/20 0.48
TSHR P16473 2/20 0.47
BLM P54132 1/20 0.45
THRB P10828 2/20 0.44
THRA P10827 1/20 0.44
TP53 P04637 2/20 0.43
LTA4H P09960 3/20 0.43
PLA2G4B P0C869 1/20 0.42
MLNR O43193 1/20 0.41
NR1I2 O75469 1/20 0.41
ESR1 P03372 1/20 0.41
NR3C1 P04150 1/20 0.41
PGR P06401 1/20 0.41
ADRB2 P07550 1/20 0.41
CHRM2 P08172 1/20 0.41
ADRB1 P08588 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
ADORA3 P0DMS8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7689289 0.98 PLA2G2A (0.49) PLA2G2ANR5A1TSHRBLMTHRB
SCHEMBL7225623 0.92 LTA4H (0.44) PLA2G2ANR5A1TSHRLTA4HCYP3A4
SCHEMBL28826013 0.85 LTA4H (0.39) PLA2G2ALTA4HLMNAMAPK1SMN1; SMN2
SCHEMBL18886699 0.83 PLA2G2A (0.68) PLA2G2ANR5A1TSHRBLMTHRB
SCHEMBL9016884 0.83 PLA2G2A (0.68) PLA2G2ANR5A1TSHRBLMTHRB
SCHEMBL8775498 0.81 AHR (0.39) PLA2G2ANR5A1TSHRLTA4HCYP3A4
SCHEMBL2094448 0.80 PLA2G2A (0.51) PLA2G2ANR5A1TSHRBLMTHRB
SCHEMBL20819718 0.80 PLA2G2A (0.51) PLA2G2ANR5A1TSHRBLMTHRB
SCHEMBL1451296 0.80 PLA2G2A (0.51) PLA2G2ANR5A1TSHRBLMTHRB
SCHEMBL1664942 0.80 PLA2G2A (0.51) PLA2G2ANR5A1TSHRBLMTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6576791-B1 Local anesthetic compounds and uses THERAVANCE, INC. 2003-06-10 US disclosed
US-6495681-B1 PRODUCING LOCAL ANESTHESIA OF LONG-DURATION. THE COMPOUNDS OF THIS INVENTION ARE MULTIBINDING COMPOUNDS THAT COMPRISE FROM 2 TO 10 LIGANDS COVALENTLY ATTACHED TO A LINKER OR LINKERS, EACH LIGAND BEING CAPABLE OF BINDING TO A LIGAND BINDING SITE THERAVANCE INC. 2002-12-17 US disclosed
US-6462034-B1 MULTIBINDING COMPOUNDS CONTAINING A SYMETRICAL DIAMINOTETRA-ETHERDODECANE RING WITH TWO SECONDARY AMIDE AND ADDITIONAL SUBSTITUENTS; VOLTAGE GATED SODIUM CHANNEL MODULATORS; LONG DURATION THERAVANCE, INC. 2002-10-08 US disclosed
US-6337423-B1 BIND TO VOLTAGE-GATED SODIUM ION CHANNELS TO MODULATE ACTIVITY ADVANCED MEDICINE, INC. 2002-01-08 US disclosed
EP-1066245-A4 NOVEL LOCAL ANESTHETIC COMPOUNDS AND USES ADVANCED MEDICINE INC (US) 2001-01-24 EP disclosed
EP-1066245-A1 NOVEL LOCAL ANESTHETIC COMPOUNDS AND USES Advanced Medicine, Inc. (US) 2001-01-10 EP disclosed
WO-1999051565-A9 NOVEL LOCAL ANESTHETIC COMPOUNDS AND USES ADVANCED MEDICINE INC (US) 1999-12-02 WO disclosed
WO-1999051565-A1 NOVEL LOCAL ANESTHETIC COMPOUNDS AND USES ADVANCED MEDICINE, INC. (US) 1999-10-14 WO disclosed